Pauls Dietrich John is President and CEO of DiaMedica Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
DiaMedica Therapeutics Inc.
26 Jun 23
4
DiaMedica Therapeutics Inc.
2 Jun 23
4
DiaMedica Therapeutics Inc.
16 Nov 22
4
DiaMedica Therapeutics Inc.
2 Jun 22
4
DiaMedica Therapeutics Inc.
16 Aug 21
4
DiaMedica Therapeutics Inc.
29 Jul 21
4
DiaMedica Therapeutics Inc.
2 Jun 20
4
DiaMedica Therapeutics Inc.
16 Aug 19
4
DiaMedica Therapeutics Inc.
26 Jun 19
4
DiaMedica Therapeutics Inc.
11 Dec 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Jun 23 | DMAC DiaMedica Therapeutics | Voting Common Shares, no par value per share | Buy | Acquire P | No | No | 3.91 | 12,787 | 50.00 k | 68,591 |
1 Jun 23 | DMAC DiaMedica Therapeutics | Stock option Common Shares | Grant | Acquire A | No | No | 2.73 | 181,000 | 494.13 k | 181,000 |
16 Nov 22 | DMAC DiaMedica Therapeutics | Voting Common Shares, no par value per share | Buy | Acquire P | No | No | 1.21 | 20,000 | 24.20 k | 55,804 |